Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.63
0.03 (5.00%)
At close: Aug 15, 2025, 3:47 PM
0.61
-2.38%
After-hours: Aug 15, 2025, 03:47 PM EDT
Brainstorm Cell Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 343K | 343K | 343K | 343K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 64K | 130K | 195K | 195K | 131K | 135K | 70K | 70K | 70K | 70K | 137K | 137K | 137K | 67K | n/a | n/a |
Gross Profit | n/a | -633K | -356K | -421K | -421K | 212K | -135K | -70K | -70K | -70K | -70K | -137K | -137K | -137K | -67K | n/a | n/a |
Operating Income | -12.31M | -11.69M | -13.31M | -16.3M | -18.76M | -21.44M | -21.55M | -22.36M | -24.5M | -24.82M | -26.12M | -24.55M | -23.09M | -24.54M | -29.82M | -29.03M | -30.3M |
Interest Income | 76K | 43K | -49.12K | -49.12K | 40.88K | 119.88K | 212K | 212K | 92K | 115K | 137K | 137K | 137K | 289K | 267K | 267K | 267K |
Pretax Income | -11.09M | -11.62M | -14.23M | -12.75M | -15.53M | -17.19M | -16.63M | -22.26M | -23.98M | -24.28M | -25.45M | -23.93M | -23.16M | -24.46M | -30.08M | -29.23M | -30.36M |
Net Income | -11.09M | -11.62M | -14.23M | -12.75M | -15.53M | -17.19M | -16.63M | -22.26M | -23.98M | -24.28M | -25.45M | -23.93M | -23.16M | -24.46M | -30.08M | -29.23M | -30.36M |
Selling & General & Admin | 7.31M | 7.04M | 8.68M | 9.38M | 9.98M | 10.69M | 10.05M | 10.41M | 10.23M | 10.87M | 10.94M | 9.53M | 9.57M | 9.3M | 9.44M | 10.4M | 9.58M |
Research & Development | 4.94M | 4.53M | 4.56M | 6.85M | 8.72M | 10.75M | 11.5M | 11.95M | 14.26M | 13.96M | 15.18M | 15.02M | 13.51M | 15.23M | 20.38M | 18.63M | 20.72M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.31M | 11.63M | 13.24M | 16.23M | 18.7M | 21.44M | 21.55M | 22.36M | 24.5M | 24.82M | 26.12M | 24.55M | 23.09M | 24.54M | 29.82M | 29.03M | 30.3M |
Interest Expense | n/a | n/a | 92K | 92K | 92K | 92K | 103K | 103K | 103K | 103K | n/a | 59K | 59K | 59K | 383K | 327K | 327K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.31M | 11.69M | 13.31M | 16.3M | 18.76M | 21.44M | 21.55M | 22.36M | 24.5M | 24.82M | 26.12M | 24.55M | 23.09M | 24.54M | 29.82M | 29.03M | 30.3M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 6.34M | 5.71M | 5.31M | 4.75M | 4.32M | 3.36M | 2.95M | 2.65M | 2.45M | 2.44M | 2.43M | 2.43M | 2.43M | 2.42M | 2.42M | 2.42M | 2.39M |
Shares Outstanding (Diluted) | 6.34M | 5.71M | 5.31M | 4.75M | 4.32M | 3.36M | 2.95M | 2.65M | 2.45M | 2.44M | 2.43M | 2.43M | 2.43M | 2.42M | 2.42M | 2.42M | 2.39M |
EPS (Basic) | -2.06 | -2.36 | -1.91 | -1.85 | -3.26 | -2.64 | -2.67 | -5.07 | -5.97 | -8.09 | -8.12 | -7.52 | -7.22 | -7.82 | -7.98 | -7.83 | -9.03 |
EPS (Diluted) | -2.06 | -2.36 | -1.91 | -1.85 | -3.26 | -4.61 | -4.64 | -7.04 | -7.94 | -8.09 | -8.12 | -7.52 | -7.22 | -7.82 | -7.98 | -7.83 | -9.03 |
EBITDA | -12.08M | -11.45M | -13.83M | -16.81M | -19.27M | -21.95M | -21.28M | -22.08M | -24.22M | -24.54M | -25.83M | -24.27M | -22.81M | -24.28M | -29.56M | -28.78M | -30.07M |
EBIT | -12.31M | -11.69M | -14.08M | -17.07M | -19.54M | -22.21M | -21.55M | -22.36M | -24.5M | -24.82M | -26.12M | -24.55M | -23.09M | -24.54M | -29.82M | -29.03M | -30.3M |
Depreciation & Amortization | 228K | 240K | 253K | 259K | 262K | 265K | 269K | 274K | 278K | 285K | 285K | 282K | 273K | 260K | 254K | 243K | 231K |